Rates of Discontinuation and Nonpublication of Hepatocellular Carcinoma Interventional Clinical Trials

被引：0
作者：
Maha AbuZarifa [1 ]
Asmaa Zakaria Alnajjar [2 ]
Khaled A. Zakout [1 ]
Mohammed B. AbuZarifa [3 ]
Mohammed W. Zimmo [4 ]
机构：
[1] Al-Quds University,Faculty of Medicine
[2] Al-Azhar University,Faculty of Medicine
[3] Ain Shams University,undefined
[4] Al Shifa Medical Complex,undefined
来源：
Egyptian Liver Journal | / 15卷 / 1期
关键词：
Hepatocellular Carcinoma; Research waste; Discontinuation; Nonpublication; Clinical trials;
D O I：
10.1186/s43066-025-00417-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical trials of antiangiogenic therapy for hepatocellular carcinoma
    Taketomi, Akinobu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 213 - 218
  • [22] Discontinuation and non-publication of clinical trials in cardiovascular medicine
    Roddick, Alistair J.
    Chan, Fiona T. S.
    Stefaniak, James D.
    Zheng, Sean L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 244 : 309 - 315
  • [23] Factors relating to nonpublication and publication bias in clinical trials in Canada: A qualitative interview study
    Morrow, Richard L.
    Mintzes, Barbara
    Gray, Garry
    Law, Michael R.
    Garrison, Scott
    Dormuth, Colin R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) : 1198 - 1206
  • [24] Interventional therapies for hepatocellular carcinoma
    Willatt, Jonathon M.
    Francis, Isaac R.
    Novelli, Paula M.
    Vellody, Ranjith
    Pandya, Amit
    Krishnamurthy, V. N.
    CANCER IMAGING, 2012, 12 (01): : 79 - 88
  • [25] Rates of discontinuation and non-publication of trials for the pharmacologic treatment of alcohol use disorder
    Hartwell, Micah
    Sajjadi, Nicholas B.
    Shepard, Samuel
    Whelan, John
    Roberts, Jamie
    Ford, Alicia Ito
    Beaman, Jason
    Vassar, Matt
    SUBSTANCE ABUSE, 2022, 43 (01) : 906 - 912
  • [26] An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials
    Traxler, Brett
    Walters, Corbin
    Adewumi, Mopileola Tomi
    Meyer, Chase
    Puckett, Madison
    Vassar, Matt
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (11) : 2529 - 2532
  • [27] Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Dyhl-Polk, Anne
    Mikkelsen, Marta Kramer
    Ladekarl, Morten
    Nielsen, Dorte Lisbet
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [28] An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials
    Brett Traxler
    Corbin Walters
    Mopileola Tomi Adewumi
    Chase Meyer
    Madison Puckett
    Matt Vassar
    International Journal of Colorectal Disease, 2021, 36 : 2529 - 2532
  • [29] Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes
    Brierley, Charlotte K.
    Zabor, Emily C.
    Komrokji, Rami S.
    DeZern, Amy E.
    Roboz, Gail J.
    Brunner, Andrew M.
    Stone, Richard M.
    Sekeres, Mikkael A.
    Steensma, David P.
    CANCER, 2020, 126 (21) : 4735 - 4743
  • [30] Combination of interventional therapies in hepatocellular carcinoma
    Lencioni, R
    Cioni, D
    Donati, F
    Bartolozzi, C
    HEPATO-GASTROENTEROLOGY, 2001, 48 (37) : 8 - 14
12345